Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
The classification of Post herpetic Neuralgia Treatment includes Anticonvulsants, Skin Patch and others, and the proportion of Anticonvulsants in 2018 is about 81.7%.

Market Analysis and Insights: Global Post herpetic Neuralgia Treatment Market
The global Post herpetic Neuralgia Treatment market size is projected to reach US$ 2105.4 million by 2027, from US$ 1599.9 million in 2020, at a CAGR of 4.0% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Post herpetic Neuralgia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Post herpetic Neuralgia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Post herpetic Neuralgia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Post herpetic Neuralgia Treatment market.

Global Post herpetic Neuralgia Treatment Scope and Market Size
Post herpetic Neuralgia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Post herpetic Neuralgia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Anticonvulsants
Skin Patch
Other

Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Arbor Pharma
Assertio Therapeutics
Endo Pharma
Teikoku Pharma
Teva
Mylan
Hengrui Medicine